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Abstract
Objective
The status of axillary lymph nodes is one of the most important prognostic factors in patients
with breast cancer. A precise noninvasive evaluation of axillary lymph node status
preoperatively, although challenging, is vital for optimization of the treatment plan for
patients. The objective of our study was to assess the utility of ultrasound and mammography
in detecting the absence of axillary lymph nodal metastasis in patients of breast cancer, taking
histopathology as gold standard.
Methods
A cross-sectional study was conducted in the Department of Radiology, Aga Khan University
Hospital, Karachi. All female patients between 20 and 95 years of age with a known diagnosis of
breast cancer with mammographic and ultrasound imaging done at our institute were included.
Patients with abnormal lymph nodes on mammography or on ultrasound, patients already
operated for breast cancer, patients who already underwent axillary lymph node dissection and
those whose histopathology reports were not available or who did not undergo surgery were
excluded.
Results
A total of 262 women with breast carcinoma who had both ultrasound and mammography done
and also had surgery performed at our institution were included. At final surgical pathology, a
total of 45 of the 262 patients (17.2%) with breast carcinoma had one or more positive lymph
nodes. Out of the total 262 patients, 217 patients were found to be true negatives as they had
absent axillary nodal metastasis on imaging as well as on histopathology. In all, 45 out of 262
patients were found to be false negatives as they had absent axillary nodal metastasis on
imaging; however, they were found to be positive for metastasis on histopathology. The
negative predictive value was 82.8%. Patient age was considered as a factor that may influence
the outcome of results; the patients were stratified into age ranges seven groups with the age
range of 10 years, ranging from 26 to 95 years. Chi-square test showed a p-value of 0.148,
which showed no significant difference in the effect of age on diagnosing the absence of
metastasis by ultrasound and mammography.
Conclusion
Our study shows that ultrasound and mammography even when used in combination cannot
safely exclude axillary metastasis and thus cannot eliminate the need for sentinel node biopsy.
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Introduction
Primary breast cancer is one of the most commonest malignancies in females worldwide [1].
Pakistan has the highest incidence rate in Asia, with approximately one in every nine women
suffering from breast cancer [2]. The Karachi cancer registry reported breast cancer as the most
common cancer (34.6%) among females in Pakistan with an estimated incidence rate of 50 in
100,000 [2-3]. The mortality and morbidity associated with high disease burden of breast
cancer can be decreased by early detection of breast cancer.
Breast imaging plays an essential role in the diagnosis and management of breast disease,
using a multimodality approach, including X-rays, ultrasound, magnetic resonance imaging,
and nuclear medicine techniques [4]. Axillary lymph node status remains the most important
breast cancer prognostic factor and is essential for establishing treatment decisions. The
standard for determining axillary involvement is sentinel lymph node biopsy (SLNB). SNLB
uses a radiotracer to identify the first node or nodes draining breast and thus the initial nodes to
encounter metastatic disease. It is usually performed at the time of surgical resection and has
an accuracy of 93.5% to 97.5% [5-8]. This invasive surgical procedure carries associated
morbidity including longer surgical time, an additional surgical scar, painful preoperative
injections, lymphedema, seroma, and possible sensory paresthesias [9,10].
Currently, no other noninvasive alternative diagnostic technique as accurate as the sentinel
lymph node technique for staging the axillary lymph nodes is known. Numerous nonsurgical
diagnostic methods including physical examination, mammography, ultrasound, computed
tomographic scan, magnetic resonance imaging, and positron emission tomographic imaging
have been used with variable success to detect lymph node involvement [11-20].
Mammography is the standard imaging modality used in screening for breast disease. The
accuracy of mammography has been previously reported to be 79.5% with a sensitivity of 21%.
Axillary ultrasound is routinely used preoperatively to evaluate the involvement of lymph
nodes. Ultrasound has accuracy of 82.8%, sensitivity 21%, and specificity 99.5% [21]. However,
accurate screening to determine whether axillary lymph nodes are involved in the metastatic
process and subsequent needle biopsy is required remains a challenge.
The objective of this study was to assess the utility of the combination of ultrasound and
mammography, taking histopathology as the gold standard, to detect negative axillary
lymphadenopathy in breast carcinoma. Therefore, we aim to increase the confidence in
declaring the axilla negative for metastatic involvement of nodes, thus potentially eliminating
the need for SNLB and saving the patient from additional pain, cost and most importantly
radiation exposure. This is the first study from the developing country of Pakistan to encourage
the widespread and appropriate use of a combination of different diagnostic modalities for
ruling out metastatic involvement of axillary lymph nodes in breast cancer patients.
Materials And Methods
This was a retrospective cross-sectional study conducted at the Department of Radiology, Aga
Khan University Hospital, Karachi. This study was conducted from July 26, 2016 to June 26, 2018
for a duration of 23 months. We included female patients between 20 and 95 years of age with a
known diagnosis of breast cancer who were referred to us from the breast surgery consulting
clinics. Patients with abnormal lymph nodes on mammography or on ultrasound, patients
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already operated for breast cancer, patients who already underwent axillary lymph node
dissection, and those whose histopathology reports were not available or who did not undergo
surgery were excluded.
Mammogram consisted of mediolateral oblique and craniocaudal views with any additional
views, if required. Mammograms were evaluated for any abnormal appearing lymph nodes by
board-certified attending radiologists with experience in women imaging of at least five years.
Lymph nodes were considered abnormal on mammogram if the size was more than 2 cm (in
short axis), or if they were irregular or rounded in shape, with spiculated margins, absence of
lucent appearing fat within the lymph node representing the loss of fatty hilum, or if the
density was increased [12].
All patients had an axillary ultrasound performed on the side of the involved breast with a
high-frequency transducer and any abnormal lymph nodes were recorded. Lymph nodes were
documented as abnormal on ultrasound if rounded in shape, long-to-short axis ratio of less
than two, appearing more hypoechoic than the surroundings, compression or disappearance of
the bright appearing fat within the lymph node, or asymmetry or thickening of the cortex [14-
15].
Patients who were found to have negative lymph node status on both the diagnostic modalities
(mammography and ultrasound) underwent a sentinel lymph node lymphoscintigraphy, as this
is the currently practiced standard for determining axillary involvement. 37 MBq of
radiolabelled 99m-Technetium was injected in the periareolar region. The patients were
scanned on GE dual-head gamma camera at 15 minutes, one hour and 24 hours depending on
whether the sentinel node was seen or not seen on the gamma camera. The hot node was
marked on the skin and operated on the next day under the guidance of a gamma probe. The
sentinel node was evaluated for histopathology by frozen section. All lymph node specimens
were reviewed by an experienced pathologist for pleomorphism to detect metastatic
involvement. The lymph nodes with and without evidence of metastatic involvement were
recorded.
Statistical analysis was done using Statistical Package for Social Sciences (SPSS v.19, IBM Corp.
in Armonk, NY). Mean and standard deviation were calculated for age. Frequency and
percentages were calculated along with true and false positive/negative rates. Effect modifiers
were controlled through stratification of age to see the effect of this on outcome variables.
Results
We identified and evaluated a total of 262 women with breast carcinoma who had both
ultrasound and mammography done and also had surgery performed at our institution. All
patients in this study had a mean age of 55.29 years ± 12.78 standard deviation (SD) with an age
range of 25 to 95 years (Figure 1).
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FIGURE 1: Histogram analysis showing age distributions
At final surgical pathology, a total of 45 of the 262 patients (17.2%) with breast carcinoma had
one or more positive lymph nodes (Table 1).
Histopathology Frequency Percentages (%)
Positive 45 17.2%
Negative 217 82.8%
TABLE 1: Histopathologic detection of axillary nodal metastasis
Out of the total 262 patients, 217 patients were found to be true negatives as they had absent
metastasis on imaging (ultrasound and mammography) as well as on histopathology. In all, 45
out of 262 patients were found to be false negatives as they had absent metastasis on imaging;
however, they were found to be positive for metastasis on histopathology (Figure 2).
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FIGURE 2: Bar chart showing imaging findings of axillary
nodal metastasis
The negative predictive value was calculated to be 82.8%. Patient age was considered as a factor
that may influence the outcome of results; the patients were stratified into seven groups with
age range of 10 years each, ranging from 26 to 95 years (Table 2).
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Age Ranges
                                     Histopathology
Total
Positive Negative
26-35 1 15 16
36-45 10 34 44
46-55 9 66 75
56-65 13 57 70
66-75 7 35 42
76-85 3 9 12
86-95 2 1 3
Total 45 217 262
TABLE 2: Post-stratification histopathology data based on age groups
Pearson chi-square P-value 0.148 (not statistically significant in the association of age groups with axillary nodal metastasis)
There were 16 patients in the age group of 26 to 35 years, histopathology was positive in one of
them, 44 patients were present in age range of 36 to 45 histopathology was positive in 10 of
them, 75 patients in age group of 46 to 55 years, histopathology was positive in nine of them,
70 patients in age group of 56 to 65 years, histopathology was positive in 13 of them, 42
patients in age group of 66 to 75 years, histopathology was positive in seven of them, 12
patients in age group of 76-85 years, histopathology was positive in three of them and three
patients in age group of 86 to 95 years, histopathology was positive in two of them (Figure 3).
Chi-square test showed a p-value of 0.148 which showed no statistically significant difference
among different age groups and the detection of axillary nodal metastasis.
FIGURE 3: Imaging findings according to age group
stratification
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Discussion
In patients with breast cancer, clinical staging and preoperative planning are of utmost
importance because positive axillary lymph node metastasis alters the treatment and surgical
options offered to patients. The capability to accumulate this information before surgery has
enhanced greatly with the arrival of new imaging and minimally invasive biopsy techniques.
Currently, no imaging modality has enough negative predictive value to avoid the need of
sentinel node biopsy to the axilla in patients where no lymph node involvement is identified.
Mammography is the standard imaging modality for the screening of breast diseases.
Mammography is a less sensitive method for axillary imaging since most of the axilla is pushed
out of the image field, and usually, only the lower part is visualized. Ultrasound is a simple test
that is used routinely to evaluate lymph node involvement preoperatively.
Our study shows that if both imaging modalities are negative for axillary metastasis, then the
patient has 82.8% chance of having negative lymph nodes on final surgical SLNB pathology.
These results are comparable to previous similar study which showed that when a combination
of physical examination, ultrasound, mammography, and magnetic resonance imaging was
negative, the patient had an 86% chance of having negative lymph nodes on final surgical SLNB
pathology [21].
False negatives were those who were declared negative for involvement of axillary nodes on
imaging but were found to be positive on final surgical histopathology. The false-negative rate
of axillary ultrasound and mammography in our study is 17.2%, which is comparable to
previously reported 16.7% and 22.9% [21-22]. This means that this still leaves approximately
17% of patients with positive metastasis despite a negative preoperative assessment (Figures
4-7).
FIGURE 4: A) Mediolateral oblique and B) craniocaudal views
of mammogram in an 82-year-old female
Large lesion with spiculated margins in the upper outer quadrant of right breast consistent with a
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neoplastic lesion (arrows). A well-defined rounded density adjacent to this suspicious lesion was a
cyst as correlated on ultrasound.
No right axillary lymphadenopathy was noted on mammogram.
FIGURE 5: Ultrasound images of right breast and axilla of the
patient
2020 Khan et al. Cureus 12(1): e6691. DOI 10.7759/cureus.6691 8 of 12
A) The suspicious neoplastic lesion is redemonstrated in the upper outer quadrant of right breast.
B) Subcentimeter lymph nodes with intact fatty hila were identified in the right axilla with thin
cortcies and were therefore considered negative for infiltration.
FIGURE 6: Radionuclide sentinel node mapping and
scintigraphy
Fifteen-min images show dense tracer uptake over the site of injections and few ill defined areas of
abnormal uptake are seen in the right axilla. One hour images redemonstrated dense tracer uptake
over the sites of injection and a well outlined and an ill defined area of abnormal tracer uptake in the
right axilla. Two nodes were marked over the skin with the help of a hot marker under the gamma
camera.
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FIGURE 7: Histopathology slides of the patient
A) Invasive ductal carcinoma involving breast tissue. The tumor is arranged in nests, tubules and
has infiltrative borders (H&E stain; 40x magnification).
B) Metastatic invasive ductal carcinoma involving sentinel lymph node (arrows) (H&E stain; 40x
magnification).
H&E, hematoxylin and eosin.
For a lymph node with metastatic involvement to be detected on imaging, a macroscopic
amount of tumor burden is necessary. Thus, all suspicious lymph nodes cannot be identified by
current imaging modalities. Although clinically vital, microscopic diseases cannot be
anticipated to be identified. Thus, the negative results on imaging are not reliable because of
the high percentage of false negatives. That is to say, a negative ultrasound and mammogram
do not exclude lymph node metastasis. The results from our study confirm that presently,
ultrasound and mammography in combination cannot consistently identify a subset of patients
with a negative assessment in whom sentinel node biopsy may be safely omitted.
One of the limitations of this study was that the cases which were found positive for axillary
metastasis on ultrasound or mammography were excluded since in our setup biopsy of the
particular positive lymph node is not conducted. Thus, whether that particular lymph node was
found positive on final surgical histopathology or not remains indeterminate. Another
limitation of our study could be that ultrasound is operator dependent, and lack of perception
of an abnormal lymph node by the operator could lead to a false-negative result.
Patient age was considered as a factor that may influence the outcome of results. Age
stratification showed the highest number of false-negative patients, 13 out of the total 45
histopathology positive cases, in the age group of 56-65 years; however, these results were
statistically insignificant (p-value: 0.148). This is in concordance to the prior study concluding
that age is an insignificant factor for determining the absence of axillary metastasis by imaging
[23]. Another large population-based study of 13,851 patients carried out by the Danish Breast
Cancer Cooperative Group showed that age was a less powerful predictor of the presence of
involved nodes [24]. Our results confirm that presently, a combination of ultrasound and
mammography cannot be safely used to determine axilla negative for axillary metastasis.
Conclusions
In conclusion, our study shows that ultrasound and mammography, even when used in
combination, cannot safely exclude axillary nodal metastasis and thus cannot eliminate the
need of sentinel node biopsy at this point in time.
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